6 hours Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & MoreZacks
SAGE and INCY suffer setbacks due to the failure of HD and CSU studies, respectively.
Biotech · Earnings · Incyte (INCY)
XSAGE and INCY suffer setbacks due to the failure of HD and CSU studies, respectively.
Biotech · Earnings · Incyte (INCY)
X